Clinical Trials Logo

Ischemic Stroke clinical trials

View clinical trials related to Ischemic Stroke.

Filter by:

NCT ID: NCT05741593 Recruiting - Stroke Clinical Trials

Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated With Antithrombotics for an Ischemic Stroke.

QUATRO
Start date: April 7, 2023
Phase:
Study type: Observational

Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.

NCT ID: NCT05738070 Completed - Clinical trials for Acute Ischemic Stroke

Susceptibility Weighted Imaging for Detection of Thrombus in Acute Ischemic Stroke.

Start date: July 1, 2021
Phase:
Study type: Observational

It is a retrospective cross-sectional study, where consecutive stroke patients with vessel occlusion on magnetic resonance angiography (MRA) will be included for the study for one year. The relation of Susceptibility vascular sign (SVS) on Susceptibility Weighted Imaging (SWI) with risk factors and territory involved and length of thrombus will correlated with the National Institutes of Health stroke scale (NIHSS).Among total number of patients included in this study the demographics of the patients will be calculated. Risk factors for stroke of the patients included in this study will tabulated. The site of occlusion will be tabulated. The mean NIHSS scale will be calculated. Presence of SVS in patients with MR angiography positive vessel occlusion will be calculate in percentage. Subgroup analysis of presence of SVS on SWI will be done. The mean length of the thrombus will be calculated in these patients with positive SVS. Correlation between SVS on SWI with the risk factor of the patient by using the chi-square test will be calculated. A Chi-square test will be done to find out the correlation between the SVS with territorial occlusion. The correlation between the NIHSS score and length of thrombus will be calculated using the Pearson test. SWI can be useful in identifying the location of the thrombus, and NIHSS can determine the thrombus length in acute stroke. A higher incidence of SVS can be associated with risk factors and it also depends upon the site of occlusion of the vessel.

NCT ID: NCT05735405 Recruiting - Ischemic Stroke Clinical Trials

Aerobic Exercise and Cognitive Training in Patients With Stroke

Start date: November 12, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the effects of aerobic exercise and BDNF on patients with ischemic and hemorrhagic stroke during a computerized cognitive training. The main questions it aims to answer are: 1. Does a moderate intensity aerobic exercise, prior to a cognitive training, allow a better performance? 2. Is it possible to exploit the timing of rehabilitation interventions to obtain greater effects? Participants will be divided in 2 groups. The experimental group will first perform 20 minutes of pedaling as a moderate intensity aerobic exercise. It will then participate in one-hour cognitive training sessions, with the aim of training attentional, working memory and executive functions. The control group will carry out the same interventions but in reverse order. The researchers will compare the results of the cognitive training in the two groups to verify if the order of the interventions influences the results themselves.

NCT ID: NCT05735301 Recruiting - Clinical trials for Endovascular Thrombectomy

MR Imaging Selection for Endovascular Treatment in Acute Ischemic Stroke at 6 to 24 Hours

MIELS
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The acute management of stroke patients requires a fast and efficient screening imaging modality. The primary modalities used to select patients for endovascular thrombectomy (EVT) are magnetic resonance imaging (MRI) and CT/MR perfusion. The investigators prospectively assessed MRI and CTP concordance/discordance and correlated the imaging on both with EVT treatment decisions and clinical outcomes to verify the validity of MRI (FVH-DWI mismatch) for the preoperative assessment of EVT in patients with an extended time window (6h to 24h).

NCT ID: NCT05734976 Enrolling by invitation - Ischemic Stroke Clinical Trials

Electroacupuncture on Modifying Inflammatory Levels of Cytokines and Metabolites in Stroke Patients.

Start date: September 14, 2022
Phase: N/A
Study type: Interventional

The study will make an association between the diagnosis of traditional Chinese medicine that establishes that the syndrome of blood stagnation generates alteration in blood flow, vascular dysfunction, and damage to the endothelium. This process is like what occurs in a stroke. It will use electroacupuncture to change this chronic inflammatory process, and to know the effects and efficacy of this technique in the regulation and modulation of to treat extensive inflammatory diseases. However, this inflammatory response must be associated with serum cholesterol levels, since they are associated with a stroke between the LDL-C/HDL-C ratio and the prognosis after a stroke.

NCT ID: NCT05734352 Enrolling by invitation - Ischemic Stroke Clinical Trials

Patient Experiences on the Stroke Unit

BIC4CVAPREMS
Start date: February 21, 2023
Phase:
Study type: Observational

In this study we want to develop and validate a PREM for patient with ischemic stroke.

NCT ID: NCT05733416 Recruiting - Occult Cancer Clinical Trials

Intensive Cancer Screening After Cryptogenic Stroke

INCOGNITO
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

The INCOGNITO Pilot Trial is a single centre pilot prospective randomized open-label blinded endpoint (PROBE) trial to assess the feasibility of a full-scale randomized trial to determine whether an occult cancer screening strategy of FDG PET/CT in addition to usual care increases the number of occult cancers diagnosed after screening compared to usual care cancer screening alone in patients with cryptogenic stroke.

NCT ID: NCT05731310 Recruiting - Clinical trials for Post-stroke Cognitive Impairment

Clinical Study of Angong Niuhuang Pill and Acupuncture on PSCI Angong Niuhuang Pill Combined With Supervised Pulse Music Electroacupuncture on Cognitive Impairment After Ischemic Stroke

Start date: August 1, 2022
Phase: Early Phase 1
Study type: Interventional

Post stroke cognitive impairment (PSCI) refers to the attainment of cognitive impairment after the clinical event of stroke A range of syndromes that impede diagnostic criteria. Epidemiologically, PSCI is one of the common complications in stroke patients

NCT ID: NCT05728333 Recruiting - Clinical trials for Stroke, Acute Ischemic

Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke

ADJUVANT
Start date: November 28, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

In patients with acute ischemic stroke secondary to large vessel occlusion, the role of intravenous adjunctive medications, such as tirofiban, or alteplase before endovascular thrombectomy has not been well investigated. This trial aim to evaluate the efficacy and safety of intravenous tirofiban versus alteplase for acute ischemic stroke patients with large vessel occlusion piror to endovascular thrombectomy.

NCT ID: NCT05726240 Not yet recruiting - Stroke, Ischemic Clinical Trials

RCT of Ghrelin in Stroke Patients

MR GENTLE
Start date: October 2023
Phase: Phase 2
Study type: Interventional

About half of the patients with acute ischemic stroke treated with endovascular thrombectomy (EVT) remain dependent on the help of others or die in the first 90 days. We hypothesize that treatment with ghrelin, started in the first six hours after stroke onset, improves early recovery and long-term functional outcome in these patients. Ghrelin is a naturally occurring hormone and mildly excitatory neurotransmitter also known as the 'hunger hormone.' Treatment with acylated ghrelin consistently improved functional and histological recovery in in vitro and in vivo models of ischemic stroke.